期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

直肠癌新辅助放化疗 被引量：13

原文传递
导出
摘要 根治性手术结合术后放化疗一度被作为国际公认的II及III期直肠癌的标准疗法。近年,新辅助放化疗逐渐受到广泛关Β。大量研究表明,㈦术后放化疗相比,新辅助放化疗结合根治性手术的多模式联合治疗在降低直肠癌的局部复发率、延长生存时间等方面均有更好的效果,特别是在提高保肛率方面具有明显的优势。2008年NCCN的直肠癌临床指南中,已将新辅助治疗作为局部进展期(T3～T4)或有系膜内淋巴结ΚΣ的低位直肠癌患者的标准疗法。随ε先进的诊断技术、更优化的放疗模式,以及更多新药及新配伍方案的引入,对直肠癌患者采取个体化的术前新辅助治疗,将使疗效得到进一步提高。
作者 周皎琳 邱辉忠
机构地区 中国医学科学院中国协和医科大学北京协和医院基本外科
出处 《中华普通外科学文献（电子版）》 2009年第1期46-49,共4页 Chinese Archives of General Surgery(Electronic Edition)
关键词 新辅助放化疗 直肠癌 临床分析 治疗方法
分类号 R735.37 [医药卫生—肿瘤]
  • 相关文献

参考文献6

  • 1邱辉忠,林国乐.开普拓在直肠癌新辅助治疗中的应用[J].中华肿瘤杂志,2006,28(8):635-636. 被引量：5
  • 2Angelita Habr-Gama M.D., Ph.D.,Rodrigo O. Perez M.D., Ph.D.,Igor Proscurshim M.S.,Viviane Rawet M.D., Ph.D.,Diego D. Pereira M.S.,Afonso H. S. Sousa M.D., Ph.D.,Desiderio Kiss M.D., Ph.D.,Ivan Cecconello M.D., Ph.D.. Absence of Lymph Nodes in the Resected Specimen After Radical Surgery for Distal Rectal Cancer and Neoadjuvant Chemoradiation Therapy: What does it Mean?[J] 2008,Diseases of the Colon & Rectum(3):277～283
  • 3M. Cambray i Amenós,M. Navarro García,J. Martí Ragué,L. Pareja Fernández,J. Pera Fábregas. Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group[J] 2007,Clinical and Translational Oncology(3):183～191
  • 4Claudio Coco M.D.,Vincenzo Valentini M.D.,Alberto Manno M.D.,Claudio Mattana M.D., F.A.S.C.R.S.,Alessandro Verbo M.D.,Numa Cellini M.D.,Maria Antonietta Gambacorta M.D.,Marcello Covino M.D.,Giovanna Mantini M.D.,Francesco Miccichè M.D.,Giorgio Pedretti M.D.,Luigi Petito M.D.,Gianluca Rizzo M.D.,Maurizio Cosimelli M.D.,Fabrizio Ambesi Impiombato M.D.,Aurelio Picciocchi M.D.. Long-Term Results After Neoadjuvant Radiochemotherapy for Locally Advanced Resectable Extraperitoneal Rectal Cancer[J] 2006,Diseases of the Colon & Rectum(3):311～318
  • 5D. R. Adams M.D.,Dr. G. J. Blatchford M.D.,K. M. Lin M.D.,C. A. Ternent M.D.,A. G. Thorson M.D.,M. A. Christensen M.D.. Use of preoperative ultrasound staging for treatment of rectal cancer[J] 1999,Diseases of the Colon & Rectum(2):159～166
  • 6Dr. Michael Dahlberg M.D.,Bengt Glimelius M.D., Ph.D.,Wilhelm Graf M.D., Ph.D.,Lars P?hlman MMD., Ph.D.. Preoperative irradiation affects functional results after surgery for rectal cancer[J] 1998,Diseases of the Colon & Rectum(5):543～549

二级参考文献12

  • 1徐建明,朱步东,Mangia Anita,Simone Gianni,Montemurro Severino,Giuliani Francesco,Maiello Evaristo,Colucci Giuseppe,Paradiso Angelo.胸苷酸合成酶和拓扑异构酶-1及Ki-67对伊立替康联合5-氟脲嘧啶治疗晚期大肠癌的预测价值[J].中华肿瘤杂志,2005,27(5):312-315. 被引量：9
  • 2周文喜,姚学仁,刘永强.术前短疗程放化疗对进展期低位直肠癌治疗的价值[J].实用临床医药杂志,2005,9(7):103-103. 被引量：2
  • 3Cersosimo RJ. Irinotecan: a new antineoplastic agent for the management of colorectal cancer. Ann Pharmacother, 1998, 32 :1324-1333.
  • 4Rothenberg ML. Efficacy and toxicity of irinotecan in patients with colorectal cancer. Semin Oncol, 1998, 25 (5 Suppl 11 ) : 39-46.
  • 5Kohne CH, van Cutsem E, Wils J, et al. Phase Ⅲ study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European organization for research and treatment of cancer gastrointestinal group study 40986. J Clin Oncol, 2005, 23 : 4856-4865.
  • 6Quintela-Fandino M, Gravalos C, Gonzalez E, et al. Irinotecan(CPT-11 )-based chemotherapy as induction treatment for advanced colorectal cancer. Anticancer Drugs, 2005,16 : 31-38.
  • 7Stein DE, Mahmoud NN, Anne PR, et al. Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum, 2003, 46: 448-453.
  • 8Douillard JY, Cunningham D, Roth AD, et al. Irinoteean combined with fluorouraeil compared with fluorouraeil alone as first-line treatment for metastatic eoloreetal cancer: A muhieentre randomized trial. Lancet, 2000, 355 : 1041-1047.
  • 9Sahz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med, 2000,343 : 905-914.
  • 10Masi G, Cupini S, Marcucci L, et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol, 2006, 13: 58-65.

共引文献4

同被引文献131

引证文献13

二级引证文献60

中华普通外科学文献（电子版）
2009年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部